Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 31

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 31
---
 not reflect the income tax (benefit) provision we are required to make. |

18

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

Neither Self-Perform Contribution, Adjusted EBITDA, Adjusted EBITDA Margin nor Self-Perform Margin is a liquidity measure, and they should not be considered as discretionary cash available to us to reinvest in the growth of our business or to distribute to stockholders or as a measure of cash that will be available to us to meet our obligations. In order to evaluate our business, we encourage you to review the financial statements included elsewhere in this prospectus, and not rely on a single financial measure to evaluate our business. Please review the reconciliation of Net Loss to Adjusted EBITDA, a calculation of Adjusted EBITDA Margin, the reconciliation of Gross Profit to Self-Perform Contribution and a calculation of Self-Perform Margin set forth below. The following table provides a reconciliation of our Net Loss, the most directly comparable financial measure presented in accordance with GAAP, to Adjusted EBITDA, and a calculation of Adjusted EBITDA Margin for the periods presented herein:

|                                                                   |                     |           Predecessor 
               For the 
            Year Ended 
          December 31, 
                  2024 |         |    |     |      |         |    |     |      |         |    |     | Pro Forma |     |   |
|:------------------------------------------------------------------|:--------------------|----------------------:|--------:|:---|:----|-----:|--------:|:---|:----|-----:|--------:|:---|:----|:----------|:----|:--|
|                                                                   | For the Years Ended 
 December 31,        |                       |         |    |     |      |         |    |     |      |         |    |     |           |     |   |
|                                                                   |                     |                  2022 |         |    |     | 2023 |         |    |     | 2024 |         |    |     |           |     |   |
|                                                                   |                     | -Dollars in thousands |         |    |     |      |         |    |     |      |         |    |     |           |     |   |
| Net loss                                                          |                     |                     $ | (82,274 | )  |     |    $ | (46,026 | )